Company news
Noveris Health Sciences Inc. (CSE:NVRS) news
Noveris Health Sciences Inc. news releases on 6ix. Latest, Sep 9, 2026: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting
Press releases & updates
Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting
September 9, 2026
Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000
August 20, 2026
Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API
August 18, 2026
Noveris Health Sciences Joins BioAlberta
July 30, 2026
Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice
June 29, 2026
Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board
June 12, 2026
Noveris Health Sciences Appoints Geoff Griffiths As Strategic Advisor To Support Commercialization And Growth Initiatives
June 8, 2026
Noveris Health Sciences Provides Corporate Update, and Announces Agreement for Acquisition of Stem Cell Distribution Business
April 29, 2026
Noveris Health Sciences Inc. Announces Signing Of Market Making Advisory Agreement With DS Market Solutions Inc.
April 22, 2026
Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering And Other Disclosure
April 20, 2026
Noveris Health Sciences Launches Investor Website and Engages Fairfax Partners Inc. for Investor Relations and Digital Marketing Services
March 13, 2026
Noveris Announces Life Offering
March 11, 2026
Noveris Announces Resignation Of CEO
March 10, 2026
Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch
March 6, 2026
Noveris Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances
February 18, 2026